LP
NNVC icon

LMR Partners’s NanoViricides NNVC Stock Holding History

LMR Partners’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,442
Closed -$84K – 435
2015
Q2 		$84K Buy
+2,442
New +$93K 0.01% 455
2014
Q2 		– Sell
-1,432
Closed -$91K – 521
2014
Q1 		$91K Buy
+1,432
New +$122K 0.01% 260

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SIP
Stoneridge Investment Partners Radnor, Pennsylvania $152M AUM 20.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

LMR Partners's NNVC Position: Q3 2015 in Review

LMR Partners sold out of NanoViricides (NNVC) in Q3 2015, closing a stake of 2,442 shares — an estimated $84K sold.

LMR Partners first reported a position in NNVC in Q1 2014 and held it in 2 quarters. The position peaked at $91K in Q1 2014. 45 funds tracked by Wall St. Rank hold NNVC as of Q3 2015.

  • LMR Partners reported no remaining NanoViricides position as of Q3 2015 after selling out during the quarter.
  • LMR Partners sold 2,442 NanoViricides shares in Q3 2015, an estimated $84K.
  • LMR Partners first reported a position in NanoViricides in Q1 2014 and held it in 2 quarters.
  • LMR Partners's NanoViricides position peaked at $91K in Q1 2014.
  • 45 funds tracked by Wall St. Rank held NanoViricides as of Q3 2015.

Based on LMR Partners's 13F filing for Q3 2015, filed 5 Nov 2015.